Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
114,849
-
Share change
-
-9,177,966
-
Total reported value
-
$446,925
-
Price per share
-
$3.97
-
Number of holders
-
3
-
Value change
-
-$11,767,308
-
Number of buys
-
1
-
Number of sells
-
42
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q3 2025
As of 30 Sep 2025 Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) had 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 114,849 shares of stock of the company.
Largest 3 holders included Carmignac Gestion, Apollon Wealth Management, LLC, and OSAIC HOLDINGS, INC..
This table shows 3 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.